GENB Generate Biomedicines, Inc.

NASDAQ

$13.80

Generate Biomedicines, Inc. (GENB) Earnings News

Earnings press releases, previews and reviews for Generate Biomedicines, Inc. (GENB), newest first.

Thursday August 6, 2026 7:00 AM ET

Generate Biomedicines Inc. Reports Second Quarter 2026 Financial Results and Provides Business Update

Thursday May 7, 2026 6:16 AM ET

Generate Biomedicines, Inc. Reports First Quarter 2026 Financial Results and Provides Business Update